Drug Database
Back to search

United States· US:65862-998_09746c0a-9656-4f1d-a380-1cbe732c8e21

Armodafinil

A armodafinil product containing armodafinil, registered in United States by Aurobindo Pharma Limited.

ATC N06BA13US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedArmodafinilATCN06BA13REGISTER NO.US:65862-998_09746c0a…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about armodafinilAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ARMODAFINIL
Manufacturer
Aurobindo Pharma Limited
Country
United States (US)
ATC code
N06BA13
ATC class
Armodafinil
Defined daily dose
0.15 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    6586299830
    30 TABLET in 1 BOTTLE (65862-998-30)
  • ndc11
    65862-998-30

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

254 interactions on record for armodafinil.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check armodafinil against other medicinesHow interaction checks work

Armodafinil · interactions on record

254 records

  • 5 severe
  • 144 moderate
  • 105 minor

Most severe, free to view

  • OlaparibL01XK01severe
  • OlaparibL01XX46severe
  • CocaineN01BC01severe
  • CocaineR02AD03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under N06BA13

Armodafinil, as other registers publish it.

All armodafinil products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b73511a4-55bd-451b-a660-3d296412c9c2
GET /v1/drugs/b73511a4-55bd-451b-a660-3d296412c9c2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "200",
  "substance": "ARMODAFINIL",
  "productndc": "65862-998",
  "dosage_form": "TABLET",
  "dea_schedule": "CIV",
  "strength_unit": "mg/1",
  "application_number": "ANDA206069",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about armodafinil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console